Skip to main content
Erschienen in: Virchows Archiv 5/2019

29.07.2019 | Original Article

Effects of subspecialty signout and group consensus on the diagnosis of microscopic colitis

verfasst von: Meenal Sharma, Christa L. Whitney-Miller, Michael G. Drage, Aaron R. Huber, Raul S. Gonzalez

Erschienen in: Virchows Archiv | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Microscopic colitis (MC) includes lymphocytic colitis (LC) and collagenous colitis (CC). Microscopic changes are required to establish these diagnoses. While criteria exist, interobserver variability has been reported previously. This has not been evaluated in the context of subspecialty signout (SSSO) or a consensus conference. We identified 133 colon biopsies diagnosed as LC, CC, MC, or normal but with mild changes insufficient for MC. All predated the introduction of SSSO at our institution. They were independently reviewed by three gastrointestinal (GI) pathologists. Cases lacking independent consensus were reviewed by the same pathologists in consensus conference to establish a final diagnosis. Individual diagnoses were compared with the consensus diagnoses, and consensus diagnoses were compared with original diagnoses made by GI and non-GI pathologists. Consensus diagnoses were normal (n = 34), LC (n = 57), and CC (n = 42). “Normal” was the diagnosis most commonly agreed upon independently (27/34 cases, P = 0.0073 versus LC, P = 0.0172 versus CC). The reviewing pathologists independently agreed with 80%, 80%, and 94% of consensus diagnoses (κ = 0.70, 0.69, and 0.91). The group consensus agreed with the diagnoses in 49 of 58 (84%) cases originally signed out by non-GI pathologists (κ = 0.77) and in 44 of 57 (77%) cases originally signed out by GI pathologists (κ = 0.63). Good interobserver agreement exists for MC, though whether GI subspecialty training improves agreement remains unclear. Group consensus may aid in diagnosis of difficult/borderline MC cases.
Literatur
1.
Zurück zum Zitat Bjornbak C, Engel PJ, Nielsen PL, Munck LK (2011) Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther 34:1225–1234CrossRef Bjornbak C, Engel PJ, Nielsen PL, Munck LK (2011) Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther 34:1225–1234CrossRef
2.
Zurück zum Zitat Munch A, Aust D, Bohr J et al (2012) Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 6:932–945CrossRef Munch A, Aust D, Bohr J et al (2012) Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 6:932–945CrossRef
3.
Zurück zum Zitat Nyhlin N, Bohr J, Eriksson S, Tysk C (2008) Microscopic colitis: a common and an easily overlooked cause of chronic diarrhoea. Eur J Intern Med 19:181–186CrossRef Nyhlin N, Bohr J, Eriksson S, Tysk C (2008) Microscopic colitis: a common and an easily overlooked cause of chronic diarrhoea. Eur J Intern Med 19:181–186CrossRef
4.
Zurück zum Zitat Tangri V, Chande N (2009) Microscopic colitis: an update. J Clin Gastroenterol 43:293–296CrossRef Tangri V, Chande N (2009) Microscopic colitis: an update. J Clin Gastroenterol 43:293–296CrossRef
5.
Zurück zum Zitat Fernández-Bañares F, Casanova MJ, Arguedas Y, Beltrán B, Busquets D, Fernández JM, Fernández-Salazar L, García-Planella E, Guagnozzi D, Lucendo AJ, Manceñido N, Marín-Jiménez I, Montoro M, Piqueras M, Robles V, Ruiz-Cerulla A, Gisbert JP, the Spanish Microscopic Colitis Group (SMCG) (2016) Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group. Aliment Pharmacol Ther 43:400–426CrossRef Fernández-Bañares F, Casanova MJ, Arguedas Y, Beltrán B, Busquets D, Fernández JM, Fernández-Salazar L, García-Planella E, Guagnozzi D, Lucendo AJ, Manceñido N, Marín-Jiménez I, Montoro M, Piqueras M, Robles V, Ruiz-Cerulla A, Gisbert JP, the Spanish Microscopic Colitis Group (SMCG) (2016) Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group. Aliment Pharmacol Ther 43:400–426CrossRef
6.
Zurück zum Zitat Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM (1989) Lymphocytic (“microscopic”) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 20:18–28CrossRef Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM (1989) Lymphocytic (“microscopic”) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 20:18–28CrossRef
7.
Zurück zum Zitat Baert F, Wouters K, D’Haens G et al (1999) Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut 45:375–381CrossRef Baert F, Wouters K, D’Haens G et al (1999) Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut 45:375–381CrossRef
8.
Zurück zum Zitat Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, Geboes K, Münch A, the Working Group of Digestive Diseases of the European Society of Pathology (ESP) and the European Microscopic Colitis Group (EMCG) (2015) Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology 66:613–626CrossRef Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, Geboes K, Münch A, the Working Group of Digestive Diseases of the European Society of Pathology (ESP) and the European Microscopic Colitis Group (EMCG) (2015) Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology 66:613–626CrossRef
9.
Zurück zum Zitat Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, Villanacci V, Becheanu G, Nunes PB, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R (2013) European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 7:827–851CrossRef Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, Villanacci V, Becheanu G, Nunes PB, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R (2013) European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 7:827–851CrossRef
10.
Zurück zum Zitat Geboes K (2008) Lymphocytic, collagenous and other microscopic colitides: pathology and the relationship with idiopathic inflammatory bowel diseases. Gastroenterol Clin Biol 32:689–694CrossRef Geboes K (2008) Lymphocytic, collagenous and other microscopic colitides: pathology and the relationship with idiopathic inflammatory bowel diseases. Gastroenterol Clin Biol 32:689–694CrossRef
11.
Zurück zum Zitat Guagnozzi D, Landolfi S, Vicario M (2016) Towards a new paradigm of microscopic colitis: incomplete and variant forms. World J Gastroenterol 22:8459–8471CrossRef Guagnozzi D, Landolfi S, Vicario M (2016) Towards a new paradigm of microscopic colitis: incomplete and variant forms. World J Gastroenterol 22:8459–8471CrossRef
12.
Zurück zum Zitat Limsui D, Pardi DS, Smyrk TC, Abraham SC, Lewis JT, Sanderson SO, Kammer PP, Dierkhising RA, Zinsmeister AR (2009) Observer variability in the histologic diagnosis of microscopic colitis. Inflamm Bowel Dis 15:35–38CrossRef Limsui D, Pardi DS, Smyrk TC, Abraham SC, Lewis JT, Sanderson SO, Kammer PP, Dierkhising RA, Zinsmeister AR (2009) Observer variability in the histologic diagnosis of microscopic colitis. Inflamm Bowel Dis 15:35–38CrossRef
13.
Zurück zum Zitat Fiehn AM, Bjørnbak C, Warnecke M, Engel PJ, Munck LK (2013) Observer variability in the histopathologic diagnosis of microscopic colitis and subgroups. Hum Pathol 44:2461–2466CrossRef Fiehn AM, Bjørnbak C, Warnecke M, Engel PJ, Munck LK (2013) Observer variability in the histopathologic diagnosis of microscopic colitis and subgroups. Hum Pathol 44:2461–2466CrossRef
14.
Zurück zum Zitat Olesen M, Eriksson S, Bohr J, Järnerot G, Tysk C (2004) Microscopic colitis: a common diarrheal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut 53:346–350CrossRef Olesen M, Eriksson S, Bohr J, Järnerot G, Tysk C (2004) Microscopic colitis: a common diarrheal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut 53:346–350CrossRef
15.
Zurück zum Zitat Vigren L, Olesen M, Benoni C, Sjöberg K (2012) Are collagenous and lymphocytic colitis different aspects of the same disease? Scand J Gastroenterol 47:1448–1453CrossRef Vigren L, Olesen M, Benoni C, Sjöberg K (2012) Are collagenous and lymphocytic colitis different aspects of the same disease? Scand J Gastroenterol 47:1448–1453CrossRef
16.
Zurück zum Zitat Milner DA Jr, Meserve EEK, Rinda Soong T, Mata DA (2017) Statistics for pathologists. Demos Medical, New York, pp 83–84 Milner DA Jr, Meserve EEK, Rinda Soong T, Mata DA (2017) Statistics for pathologists. Demos Medical, New York, pp 83–84
17.
Zurück zum Zitat Fernandez-Banares F, Salas A, Esteve M (2008) Pitfalls and errors in the diagnosis of collagenous and lymphocytic colitis. J Crohns Colitis 2:343–347CrossRef Fernandez-Banares F, Salas A, Esteve M (2008) Pitfalls and errors in the diagnosis of collagenous and lymphocytic colitis. J Crohns Colitis 2:343–347CrossRef
18.
Zurück zum Zitat Salas A, Fernandez-Banares F, Casalots J, Gonzalez C, Tarroch X, Forcada P, Gonzalez G (2003) Subepithelial myofibroblasts and tenascin expression in microscopic colitis. Histopathology 43:48–54CrossRef Salas A, Fernandez-Banares F, Casalots J, Gonzalez C, Tarroch X, Forcada P, Gonzalez G (2003) Subepithelial myofibroblasts and tenascin expression in microscopic colitis. Histopathology 43:48–54CrossRef
19.
Zurück zum Zitat Anagnostopoulos I, Schuppan D, Riecken EO, Gross UM, Stein H (1999) Tenascin labelling in colorectal biopsies: a useful marker in the diagnosis of collagenous colitis. Histopathology 34:425–431CrossRef Anagnostopoulos I, Schuppan D, Riecken EO, Gross UM, Stein H (1999) Tenascin labelling in colorectal biopsies: a useful marker in the diagnosis of collagenous colitis. Histopathology 34:425–431CrossRef
20.
Zurück zum Zitat Mohamed N, Marais M, Bezuidenhout J (2011) Microscopic colitis as a missed cause of chronic diarrhea. World J Gastroenterol 17:1996–2002CrossRef Mohamed N, Marais M, Bezuidenhout J (2011) Microscopic colitis as a missed cause of chronic diarrhea. World J Gastroenterol 17:1996–2002CrossRef
21.
Zurück zum Zitat Tysk C, Bohr J, Nyhlin N, Wickbom A, Eriksson S (2008) Diagnosis and management of microscopic colitis. World J Gastroenterol 14:7280–7288CrossRef Tysk C, Bohr J, Nyhlin N, Wickbom A, Eriksson S (2008) Diagnosis and management of microscopic colitis. World J Gastroenterol 14:7280–7288CrossRef
22.
Zurück zum Zitat Sarewitz SJ (2014) Subspecialization in community pathology practice. Arch Pathol Lab Med 138:871–872CrossRef Sarewitz SJ (2014) Subspecialization in community pathology practice. Arch Pathol Lab Med 138:871–872CrossRef
Metadaten
Titel
Effects of subspecialty signout and group consensus on the diagnosis of microscopic colitis
verfasst von
Meenal Sharma
Christa L. Whitney-Miller
Michael G. Drage
Aaron R. Huber
Raul S. Gonzalez
Publikationsdatum
29.07.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 5/2019
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-019-02629-2

Weitere Artikel der Ausgabe 5/2019

Virchows Archiv 5/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …